Korro Bio (KRRO) Consolidated Net Income (2019 - 2025)
Korro Bio's Consolidated Net Income history spans 7 years, with the latest figure at $67.8 million for Q4 2025.
- For the quarter ending Q4 2025, Consolidated Net Income rose 418.8% year-over-year to $67.8 million, compared with a TTM value of $556000.0 through Dec 2025, up 100.66%, and an annual FY2025 reading of $556000.0, up 100.66% over the prior year.
- Consolidated Net Income for Q4 2025 was $67.8 million at Korro Bio, up from -$18.1 million in the prior quarter.
- The five-year high for Consolidated Net Income was $67.8 million in Q4 2025, with the low at -$25.8 million in Q2 2025.
- Average Consolidated Net Income over 5 years is -$15.3 million, with a median of -$20.7 million recorded in 2021.
- Year-over-year, Consolidated Net Income crashed 511.02% in 2023 and then skyrocketed 418.8% in 2025.
- Tracing KRRO's Consolidated Net Income over 5 years: stood at -$21.5 million in 2021, then skyrocketed by 128.77% to $6.2 million in 2022, then crashed by 511.02% to -$25.4 million in 2023, then increased by 16.39% to -$21.3 million in 2024, then skyrocketed by 418.8% to $67.8 million in 2025.
- Per Business Quant, the three most recent readings for KRRO's Consolidated Net Income are $67.8 million (Q4 2025), -$18.1 million (Q3 2025), and -$25.8 million (Q2 2025).